Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 18/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3340931 | 0.87 | GPR119 (0.56) | GPR119CYP2C9 | |
| SCHEMBL3343172 | 0.77 | GPR119 (0.55) | GPR119CYP2C9 | |
| SCHEMBL3343583 | 0.74 | GPR119 (0.56) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3342675 | 0.72 | GPR119 (0.52) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3344970 | 0.71 | GPR119 (0.45) | GPR119 | |
| SCHEMBL3344227 | 0.70 | GPR119 (0.53) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3342560 | 0.70 | GPR119 (0.55) | GPR119CYP2C9KCNH2 | |
| SCHEMBL31145296 | 0.68 | KDM4E (0.39) | GPR119CYP2C9LMNANPSR1 | |
| SCHEMBL3343199 | 0.64 | GPR119 (0.55) | GPR119CYP2C9KCNH2 | |
| SCHEMBL3343133 | 0.64 | GPR119 (0.64) | GPR119CYP2C9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010048149-A2 | HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |